DMT310-009 Topical in the Treatment of Acne Vulgaris
Trial details
- Registry ID
- NCT06090721
- Drugs studied
- DMT310
TrialRedline tracks 1 clinical trial sponsored by Dermata Therapeutics: 1 Phase 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| DMT310-009 Topical in the Treatment of Acne VulgarisNCT06090721 | DMT310 | Completed | 2025-03-31Actual |
Names as written in the registry records.